We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+10.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.53B
AUM Growth
-$60.5M
(-1.7%)
Cap. Flow
-$649M
Cap. Flow
% of AUM
-18.37%
Top 10 Holdings %
Top 10 Hldgs %
46.78%
Holding
411
New
105
Increased
79
Reduced
73
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$198M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$140M |
| 3 |
TIF
Tiffany & Co.
TIF
|
+$119M |
| 4 |
CY
Cypress Semiconductor
CY
|
+$76M |
| 5 |
MDCO
Medicines Co
MDCO
|
+$64.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$545M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$231M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$170M |
| 4 |
AABA
Altaba Inc
AABA
|
+$72.2M |
| 5 |
Accel Entertainment
ACEL
|
+$33.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.08% |
| 2 | Consumer Discretionary | 8.09% |
| 3 | Real Estate | 7.1% |
| 4 | Financials | 7.07% |
| 5 | Industrials | 3.4% |
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q4 2019 Portfolio in Review
As of Q4 2019, UBS O'Connor held 411 positions worth $3.53B, down 1.7% from $3.59B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
UBS O'Connor withdrew a net $649M in Q4 2019, closing 94 positions and reducing 73 holdings. Its most notable exit was Celgene Corp, an estimated $545M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Real Estate.
Against the trend, UBS O'Connor opened a new position in TD Ameritrade Holding Corp worth $160M.
- UBS O'Connor's largest Q4 2019 buy was TD Ameritrade Holding Corp: 3,221,718 shares worth $160M.
- UBS O'Connor added most to Wellcare Health Plans, Inc. in Q4 2019, an estimated $198M increase.
- UBS O'Connor's biggest Q4 2019 reduction was Post Holdings, cutting an estimated $31.4M.
- UBS O'Connor fully exited Celgene Corp in Q4 2019, selling an estimated $545M.
- UBS O'Connor's ten largest holdings make up 47% of its $3.53B portfolio in Q4 2019.
- UBS O'Connor opened 105 new positions and closed 94 in Q4 2019.
- UBS O'Connor's portfolio value fell 1.7% quarter-over-quarter to $3.53B.
Based on UBS O'Connor's 13F filing for Q4 2019, filed 14 Feb 2020.